Skip to main content

Advertisement

SpringerLink
Log in

Intravenous siRNA of Brain Cancer with Receptor Targeting and Avidin–Biotin Technology

  • Research Paper
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose

The effective delivery of short interfering RNA (siRNA) to brain following intravenous administration requires the development of a delivery system for transport of the siRNA across the brain capillary endothelial wall, which forms the blood–brain barrier in vivo.

Methods

siRNA was delivered to brain in vivo with the combined use of a receptor-specific monoclonal antibody delivery system, and avidin–biotin technology. The siRNA was mono-biotinylated on either terminus of the sense strand, in parallel with the production of a conjugate of the targeting MAb and streptavidin.

Results

Rat glial cells (C6 or RG-2) were permanently transfected with the luciferase gene, and implanted in the brain of adult rats. Following the formation of intra-cranial tumors, the rats were treated with a single intravenous injection of 270 μg/kg of biotinylated siRNA attached to a transferrin receptor antibody via a biotin–streptavidin linker. The intravenous administration of the siRNA caused a 69–81% decrease in luciferase gene expression in the intracranial brain cancer in vivo.

Conclusions

Brain delivery of siRNA following intravenous administration is possible with siRNAs that are targeted to brain with the combined use of receptor specific antibody delivery systems and avidin–biotin technology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. M. T. McManus, P. A. Sharp. Gene silencing in mammals by small interfering RNAs. Nat. Rev. Genet. 3:737–747 (2002).

    Article  PubMed  CAS  Google Scholar 

  2. P. J. Paddison, A. A. Caudy, E. Bernstein, G. J. Hannon, D. S. Conklin. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev. 16:948–958 (2002).

    Article  PubMed  CAS  Google Scholar 

  3. S. Spagnou, A. D. Miller, M. Keller. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA. Biochemistry 43:13348–13356 (2004).

    Article  PubMed  CAS  Google Scholar 

  4. A. Jahraus, T. E. Tjelle, T. Berg, A. Habermann, B. Storrie, O. Ullrich, et al. In vitro fusion of phagosomes with different endocytic organelles from J774 macrophages. J. Biol. Chem. 273:30379–30390 (1998).

    Article  PubMed  CAS  Google Scholar 

  5. W. M. Pardridge. shRNA and siRNA delivery to the brain. Adv. Drug Deliv. Rev. 59:141–152 (2007).

    Article  PubMed  CAS  Google Scholar 

  6. Y. Zhang, Y. F. Zhang, J. Bryant, A. Charles, R. J. Boado, W. M. Pardridge. Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer. Clin. Cancer Res. 10:3667–3677 (2004).

    Article  PubMed  CAS  Google Scholar 

  7. N. M. Green. Avidin and streptavidin. Methods Enzymol. 184:51–67 (1990).

    PubMed  CAS  Google Scholar 

  8. T. Suzuki, D. Wu, F. Schlachetzki, J. Y. Li, R. J. Boado, W. M. Pardridge. Imaging endogenous gene expression in brain cancer in vivo with 111In-peptide nucleic acid antisense radiopharmaceuticals and brain drug-targeting technology. J. Nucl. Med. 45:1766–1775 (2004).

    PubMed  CAS  Google Scholar 

  9. W. M. Pardridge, Y. S. Kang, J. L. Buciak, J. Yang. Human insulin receptor monoclonal antibody undergoes high affinity binding to human brain capillaries in vitro and rapid transcytosis through the blood–brain barrier in vivo in the primate. Pharm. Res. 12:807–816 (1995).

    Article  PubMed  CAS  Google Scholar 

  10. W. M. Pardridge, J. L. Buciak, P. M. Friden. Selective transport of an anti-transferrin receptor antibody through the blood–brain barrier in vivo. J. Pharmacol. Exp. Ther. 259:66–70 (1991).

    PubMed  CAS  Google Scholar 

  11. H. J. Lee, B. Engelhardt, J. Lesley, U. Bickel, W. M. Pardridge. Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood–brain barrier in mouse. J. Pharmacol. Exp. Ther. 292:1048–1052 (2000).

    PubMed  CAS  Google Scholar 

  12. W. M. Pardridge, R. J. Boado, Y. S. Kang. Vector-mediated delivery of a polyamide (“peptide”) nucleic acid analogue through the blood–brain barrier in vivo. Proc. Natl. Acad. Sci. U.S.A. 92:5592–5596 (1995).

    Article  PubMed  CAS  Google Scholar 

  13. D. Wu, J. Yang, W. M. Pardridge. Drug targeting of a peptide radiopharmaceutical through the primate blood–brain barrier In vivo with a monoclonal antibody to the human insulin receptor. J. Clin. Invest. 100:1804–1812 (1997).

    Article  PubMed  CAS  Google Scholar 

  14. R. J. Boado, W. M. Pardridge. Ten nucleotide cis element in the 3-untranslated region of the GLUT1 glucose transporter mRNA increases gene expression via mRNA stabilization. Brain Res. Mol. Brain Res. 59:109–113 (1998).

    Article  PubMed  CAS  Google Scholar 

  15. Y. Zhang, R. J. Boado, W. M. Pardridge. In vivo knockdown of gene expression in brain cancer with intravenous RNAi in adult rats. J. Gene Med. 5:1039–1045 (2003).

    Article  PubMed  CAS  Google Scholar 

  16. S. M. Elbashir, J. Harborth, K. Weber, T. Tuschl. Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 26:199–213 (2002).

    Article  PubMed  CAS  Google Scholar 

  17. R. F. Barth. Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas. J. Neurooncol. 36:91–102 (1998).

    Article  PubMed  CAS  Google Scholar 

  18. Y. L. Chiu, T. M. Rana. RNAi in human cells: basic structural and functional features of small interfering RNA. Mol. Cell 10:549–561 (2002).

    Article  PubMed  CAS  Google Scholar 

  19. A. de Fougerolles, M. Manoharan, R. Meyers, H. P. Vornlocher. RNA interference in vivo: toward synthetic small inhibitory RNA-based therapeutics. Methods Enzymol. 392:278–296 (2005).

    PubMed  Google Scholar 

  20. I. Pilz, E. Schwarz, W. Durchschein, A. Licht, M. Sela. Effect of cleaving interchain disulfide bridges on the radius of gyration and maximum length of anti-poly(d-alanyl) antibodies before and after reaction with tetraalanine hapten. Proc. Natl. Acad. Sci. USA. 77:117–121 (1980).

    Article  PubMed  CAS  Google Scholar 

  21. M. Grzelinski, B. Urban-Klein, T. Martens, K. Lamszus, U. Bakowsky, S. Hobel, F. Czubayko, A. Aigner. RNA interference-mediated gene silencing of pleiotrophin though polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts. Hum. Gene Ther. 17:751–766 (2006).

    Article  PubMed  CAS  Google Scholar 

  22. Y. K. Song, F. Liu, S. Chu, D. Liu. Characterization of cationic liposome-mediated gene transfer in vivo by intravenous administration. Hum. Gene Ther. 8:1585–1594 (1997).

    PubMed  CAS  Google Scholar 

  23. K. Miyawaki-Shimizu, D. Predescu, J. Shimizu, M. Broman, S. Predescu, A. B. Malik. siRNA-induced caveolin-1 knockdown in mice increases lung vascular permeability via the junctional pathwayAm. J. Physiol. Lung. Cell. Mol. Physiol. 290:L405–L413 (2006).

    Article  PubMed  CAS  Google Scholar 

  24. P. Kumar, H. Wu, J. L. McBride, K.-E. Jung, M. H. Kim, B. L. Davidson, S. K. Lee, P. Shankar, N. Manjunath. Transvascular delivery of small interfering RNA to the central nervous systemNature. 448:39–43 (2007).

    Article  PubMed  CAS  Google Scholar 

  25. B. T. Hawkins, R. D. Egleton, T. P. Davis. Modulation of cerebral microvascular permeability by endothelial nicotinic acetylcholine receptors. Am. J. Physiol. Heart Circ. Physiol. 289:H212–H219 (2005).

    Article  PubMed  CAS  Google Scholar 

  26. H. J. Lee, Y. Zhang, C. Zhu, K. Duff, W. M. Pardridge. Imaging brain amyloid of Alzheimer disease in vivo in transgenic mice with an Abeta peptide radiopharmaceutical. J. Cereb. Blood Flow Metab. 22:223–231 (2002).

    Article  PubMed  CAS  Google Scholar 

  27. S. M. Elbashir, J. Harborth, W. Lendeckel, A. Yalcin, K. Weber, T. Tuschl. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494–498 (2001).

    Article  PubMed  CAS  Google Scholar 

  28. M. Egli, G. Minasov, V. Tereshko, P. S. Pallan, M. Teplova, G. B. Inamati, E. A. Lesnik, S. R. Owens, B. S. Ross, T. P. Prakash, M. Manoharan. Probing the influence of stereoelectronic effects on the biophysical properties of oligonucleotides: comprehensive analysis of the RNA affinity, nuclease resistance, and crystal structure of ten 2-O-ribonucleic acid modifications. Biochemistry 44:9045–9057 (2005).

    Article  PubMed  CAS  Google Scholar 

  29. T. Yoshikawa, W. M. Pardridge. Biotin delivery to brain with a covalent conjugate of avidin and a monoclonal antibody to the transferrin receptorJ. Pharmacol. Exp. Ther. 263:897–903 (1994).

    Google Scholar 

  30. M. L. Penichet, Y. S. Kang, W. M. Pardridge, S. L. Morrison, S.U. Shin. An antibody-avidin fusion protein specific for the transferrin receptor serves as a delivery vehicle for effective brain targeting: initial applications in anti-HIV antisense drug delivery to the brain. J. Immunol. 163:4421–4426 (1999).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, UCLA, Warren Hall 13-164, 900 Veteran Ave., Los Angeles, California, USA

    Chun-Fang Xia, Yun Zhang, Ruben J. Boado & William M. Pardridge

  2. ArmaGen Technologies, Inc., Santa Monica, California, USA

    Yufeng Zhang, Yun Zhang & Ruben J. Boado

Authors
  1. Chun-Fang Xia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yufeng Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yun Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ruben J. Boado
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. William M. Pardridge
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to William M. Pardridge.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xia, CF., Zhang, Y., Zhang, Y. et al. Intravenous siRNA of Brain Cancer with Receptor Targeting and Avidin–Biotin Technology. Pharm Res 24, 2309–2316 (2007). https://doi.org/10.1007/s11095-007-9460-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11095-007-9460-8

Key words

Search

Navigation